在肝硬化患者中食道变分级和血小板计数
Muhammad Farooq1,2, Usman Sadiq1, Qaiser Wadud3
1Department of General Medicine, Nishtar Medical University, Multan, PAK.
Cureus
|September 25, 2025
概括
肝硬化患者血小板数量低与严重的食道静脉瘤有关. 血小板缺血可以预测高度的静脉,有助于进行内镜查的非侵入性风险评估.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 血液学 血液学 血液学
背景情况:
- 食道静脉是肝硬化的一种严重并发症,与等级相关的出血风险.
- 上部胃肠内镜 (UGIE) 是检测的标准,但具有侵入性和资源密集性.
- 像血小板计数这样的非侵入性标志物可以帮助分层风险,并指导肝硬化患者的内镜查.
研究的目的:
- 为了确定食道水等级和血小板计数在肝硬化中的关系.
- 为了评估血小板缺血的有效性作为高度食道静脉的预测.
主要方法:
- 一项观察性描述性研究,从2022年8月到2023年8月,涉及120名肝硬化患者.
- 收集人口,临床和实验室数据,包括血小板计数.
- 分析了血小板计数和水等级 (I-III) 之间的相关性,使用千二测试,赔率比率和后勤回归.
主要成果:
- 血小板计数和食道水严重程度之间存在显著的逆相关性.
- 血小板缺血 (<100×109/L) 独立预测的高度 (III级) 静脉.
- 儿童-图尔科特-皮格C级与高度的静脉动脉相关;年龄和并不是显著的预测因素.
结论:
- 血小板缺血与肝硬化中晚期食道静脉瘤密切相关.
- 血小板计数作为一个有价值的,非侵入性指标,用于识别高风险的肝硬化患者.
- 纳入血小板计数可以改善风险分层,并优化内镜查策略,特别是在资源有限的环境中.
相关概念视频
01:28Esophageal Varices-II: Clinical Features and Management
374
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
374
01:24Esophageal Varices-I: Introduction
1.2K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.2K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
214
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
214
01:30Venous Thrombosis IV: Nursing Management
201
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
201